Jazz Pharmaceuticals PLC's ticker is and the CUSIP is 00B4Q5ZN4. A total of 1 filers reported holding Jazz Pharmaceuticals PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $6,446,676 | +7.9% | 52,412 | +13.6% | 0.03% | -8.3% |
| Q3 2023 | $5,974,303 | +10.4% | 46,155 | +5.8% | 0.04% | +16.1% |
| Q2 2023 | $5,410,671 | -14.5% | 43,645 | +0.9% | 0.03% | -22.5% |
| Q1 2023 | $6,329,065 | -1.7% | 43,252 | +7.0% | 0.04% | -11.1% |
| Q4 2022 | $6,437,398 | -99.8% | 40,408 | +58.1% | 0.04% | +73.1% |
| Q3 2022 | $3,407,559,000 | -10.9% | 25,565 | +4.3% | 0.03% | -3.7% |
| Q2 2022 | $3,823,805,000 | +13.6% | 24,510 | +13.3% | 0.03% | +35.0% |
| Q1 2022 | $3,366,364,000 | -14.0% | 21,625 | -29.6% | 0.02% | -13.0% |
| Q4 2021 | $3,913,346,000 | -0.0% | 30,717 | +2.2% | 0.02% | -8.0% |
| Q3 2021 | $3,915,284,000 | +105.9% | 30,069 | +181.0% | 0.02% | +92.3% |
| Q2 2021 | $1,901,103,000 | +70.7% | 10,702 | +6.0% | 0.01% | 0.0% |
| Q2 2020 | $1,113,662,000 | -22.1% | 10,093 | -29.6% | 0.01% | -38.1% |
| Q1 2020 | $1,429,474,000 | -38.2% | 14,332 | -7.5% | 0.02% | -8.7% |
| Q4 2019 | $2,313,840,000 | -33.5% | 15,500 | -42.9% | 0.02% | -41.0% |
| Q3 2019 | $3,478,360,000 | -9.1% | 27,145 | +1.2% | 0.04% | -11.4% |
| Q2 2019 | $3,825,312,000 | +67.6% | 26,833 | +68.1% | 0.04% | +69.2% |
| Q1 2019 | $2,282,483,000 | +54.2% | 15,967 | +56.6% | 0.03% | +13.0% |
| Q1 2017 | $1,479,745,000 | -78.4% | 10,196 | -79.1% | 0.02% | -84.4% |
| Q4 2015 | $6,858,344,000 | – | 48,793 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | 51,967 | $8,577,000 | 0.10% |